Mylan launches generic contraceptive

Norethindrone tablets launched in the 0.35 mg strength

PITTSBURGH — Mylan has launched a generic version of a Johnson & Johnson contraceptive, the company said Wednesday.

Mylan announced the launch of norethindrone tablets in the 0.35 mg strength. The drug is a generic version of Micronor, made by J&J subsidiary Janssen Pharmaceuticals. A company partnering with Mylan on the drug, Famy Care, received approval from the Food and Drug Administration for the drug.

Various versions of the drug had sales of about $57.2 million during the 12-month period that ended in March, according to IMS Health.

 

Recommended stories

Login or Register to post a comment.